menu
    • menu

    Company profile for Hope Medicine

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hope Medicine, also known as HopeMed, stands as a science-driven and patient-centric clinical-stage biotech company, conducting research and development in prominent innovation hubs across China. Our dedication lies in the exploration, advancement, and commercialization of pioneering, secure, efficacious, and affordable medications tailored for extensive yet underserved patient communities. Strategically, we are constructing a...
    Hope Medicine, also known as HopeMed, stands as a science-driven and patient-centric clinical-stage biotech company, conducting research and development in prominent innovation hubs across China. Our dedication lies in the exploration, advancement, and commercialization of pioneering, secure, efficacious, and affordable medications tailored for extensive yet underserved patient communities. Strategically, we are constructing a resilient pipeline specializing in endocrine, cardiovascular, and metabolic diseases, with a particular emphasis on women's health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hope MedicineChina Flag
    Country
    Country
    China
    Address
    Address
    No.112 Liangxiu Road,Pudong
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hopemedinc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hopemedicineinc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bioinvent Achieves Phase 3 Milestone For HMI-115 In Endometriosis
    Bioinvent Achieves Phase 3 Milestone For HMI-115 In Endometriosis

    26 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-26/bioinvent-achieves-phase-3-milestone-for-hmi-115-in-endometriosis

    PHARMIWEB
    26 Mar 2026
    Share Share
    FDA Fast-Tracks HMI-115 to Accelerate Hope Med Development
    FDA Fast-Tracks HMI-115 to Accelerate Hope Med Development

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hope-medicine-incs-hmi-115-received-us-fda-fast-track-designation-accelerating-global-development-302632958.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share
    Hope Medicine Reports Ph2 Success for Endometriosis Therapy
    Hope Medicine Reports Ph2 Success for Endometriosis Therapy

    07 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hope-medicine-inc-announces-successful-completion-of-a-global-phase-2-study-of-a-potential-first-in-class-endometriosis-treatment-302577257.html

    PR NEWSWIRE
    07 Oct 2025
    Share Share
    Hope Medicine Announces Positive Ph 2 Study Results For Endometriosis
    Hope Medicine Announces Positive Ph 2 Study Results For Endometriosis

    23 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hope-medicine-inc-announces-positive-results-from-a-global-phase-2-study-of-a-first-in-class-endometriosis-treatment-and-breakthrough-therapy-designation-302284499.html

    PR NEWSWIRE
    23 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search